Mark L. Stevens

A New Potential Strategy for Acute Non-Alcoholic Steatohepatitis (NASH)

M. Sierra-Hoffman, A. Sekhon, Aniruddha Gollapalli, 2021, The American journal of case reports.

Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study

E. Pineda, M. Pineda, M. Sierra, 2022, Frontiers in Pharmacology.

Upper extremity Histoplasma capsulatum treatment with isavuconazole

M. Sierra-Hoffman, D. R. Perkins, Mark L. Stevens, 2021, IDCases.

Rickettsia typhi central nervous system infection

L. Tran, M. Sierra-Hoffman, Mark L. Stevens, 2020, IDCases.

A multi-mechanism approach reduces length of stay in the ICU for severe COVID-19 patients

Vincent VanBuren, E. Pineda, M. Sierra-Hoffman, 2021, PloS one.

Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital

M. Sierra-Hoffman, Jason J. Zhang, Mark L. Stevens, 2021, PloS one.

Successful treatment of a prosthetic hip infection due to Enterococcus faecalis with sequential dosing of oritavancin and prosthesis preservation without prosthetic joint surgical manipulation

M. Sierra-Hoffman, Mark L. Stevens, Brian X. Contreras, 2020, IDCases.

Thymoma Causing Bilateral Upper Extremity Deep Vein Thrombosis

M. Sierra-Hoffman, H. Bui, Rafael Deliz-Aguirre, 2020, Respiratory medicine case reports.

Rickettsia typhi infection presenting as severe ARDS

L. Tran, Rafael Deliz-Aguirre, Mark L. Stevens, 2019, IDCases.